Boothbay Fund Management’s SeaStar Medical ICU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,400
Closed -$3.56M 2397
2022
Q2
$3.56M Sell
1,400
-38
-3% -$96.3K 0.09% 310
2022
Q1
$3.64M Hold
1,438
0.08% 322
2021
Q4
$3.61M Hold
1,438
0.09% 289
2021
Q3
$3.61M Sell
1,438
-10
-0.7% -$24.8K 0.1% 248
2021
Q2
$3.59M Hold
1,448
0.12% 203
2021
Q1
$3.55M Buy
+1,448
New +$3.55M 0.13% 161

Other funds holding ICU

Boothbay Fund Management's ICU Position: Q3 2022 in Review

Boothbay Fund Management sold out of SeaStar Medical (ICU) in Q3 2022, closing a stake of 1,400 shares — an estimated $3.56M sold.

Boothbay Fund Management first reported a position in ICU in Q1 2021 and held it in 6 quarters. The position peaked at $3.64M in Q1 2022. 48 funds tracked by Wall St. Rank hold ICU as of Q3 2022.

  • Boothbay Fund Management reported no remaining SeaStar Medical position as of Q3 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 1,400 SeaStar Medical shares in Q3 2022, an estimated $3.56M.
  • Boothbay Fund Management first reported a position in SeaStar Medical in Q1 2021 and held it in 6 quarters.
  • Boothbay Fund Management's SeaStar Medical position peaked at $3.64M in Q1 2022.
  • 48 funds tracked by Wall St. Rank held SeaStar Medical as of Q3 2022.

Based on Boothbay Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.